Jinxin Fertility Group Limited (abbrev. JXR) filed a Next Day Disclosure Return with the Hong Kong Stock Exchange on 2 June 2026, detailing the latest movement in its share capital and buy-back programme.

Key takeaways

1. Latest transaction • On 2 June 2026, JXR repurchased 1.04 million ordinary shares on the Exchange at HKD 2.33–2.34 each, for a total consideration of HKD 2.42 million. • All 1.04 million shares are earmarked for cancellation.

2. Share capital status • Issued shares (excluding treasury shares) stood unchanged at 2.71 billion as of both 29 May and 2 June 2026. • The newly repurchased shares, together with earlier buy-backs pending cancellation since 27 March 2026, bring the outstanding yet-to-be-cancelled total to 47.99 million shares, equivalent to about 1.78 % of current issued share capital.

3. Utilisation of the 2025 buy-back mandate • Shareholders granted authority on 26 June 2025 for the company to repurchase up to 274.47 million shares. • To date, 87.65 million shares have been bought back under this mandate, representing 3.19 % of the share base at the time of approval.

4. Trading blackout for new issues • In line with Hong Kong Listing Rules, JXR is restricted from issuing new shares or dealing in treasury shares until 2 July 2026 (30 days after the latest repurchase).

The company confirmed that all repurchases complied with Main Board Rule 10.06 and that no material changes have been made to the explanatory statement filed on 4 June 2025.